| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070533 | European Journal of Surgical Oncology (EJSO) | 2005 | 8 Pages |
Abstract
These improvements in outcome should become the gold standard to which all other therapeutic regimens should be compared. Poor surgical quality and related poor results should not be a justification for multimodality regimen.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T. Lerut, Ph. Nafteux, J. Moons, W. Coosemans, G. Decker, P. De Leyn, D. Van Raemdonck,